journal article·2006-04

Fabrication and characterization of heparin functionalized membrane-mimetic assemblies

Po-Yuan Tseng, Shyam M. Rele, Xue-Long Sun, Elliot L. Chaikof

Biomaterials· Volume 27· Issue 12
Publisher page

Abstract

A membrane-mimetic assembly incorporating surface bound heparin was fabricated as a system to improve the hemocompatibility of blood-contacting devices. As a model system, heparin was chemically modified by end-point conjugation to biotin and immobilized onto membrane-mimetic thin films via biotin-streptavidin interactions. Heparin surface density, determined by radiochemical titration, confirmed that surface density was directly related to the molar concentration of biotinylated lipid within the assembled membrane-mimetic film. The capacity of surface bound heparin to promote ATIII-mediated thrombin inactivation was investigated in a parallel plate flow chamber under simulated venous and arterial wall shear rates of 50 and 500 s(-1), respectively. Significantly, we observed that the rate of thrombin inactivation approached a maximum at a heparin surface concentration greater than 4.4 pmol/cm(2) (61 ng/cm(2)). In the process, mass transport limited regimes were identified for heparin potentiated thrombin inactivation under both simulated venous and arterial conditions.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Blood Coagulation and Thrombosis Mechanisms · Polymer Surface Interaction Studies · Platelet Disorders and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Preparation of heparin and its use in the first clinical cases10.1161/01.CIR.19.1.79 ↗
2. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism10.1016/0002-9343(89)80523-6 ↗
3. Glycosaminoglycans and the regulation of blood coagulation10.1042/bj2890313 ↗
4. The kinetics of hemostatic enzyme–antithrombin interactions in the presence of low molecular weight heparin10.1016/S0021-9258(19)70431-1 ↗
5. Fractionation of low molecular weight heparin species and their interaction with antithrombin10.1016/S0021-9258(17)30159-X ↗
6. Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate10.1016/0049-3848(82)90244-4 ↗
7. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin10.1016/S0021-9258(18)34385-0 ↗
8. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin–thrombin reaction. Elucidation from salt concentration effects10.1016/S0021-9258(18)38125-0 ↗
9. Mechanism of thrombin inhibition by antithrombin and heparin cofactor II in the presence of heparin10.1016/S0142-9612(96)00125-1 ↗
10. Heparin free long-term extracorporeal circulation using bioactive surfaces10.1097/00002216-198907000-00152 ↗
11. Heparin immobilization onto segmented polyurethane-urea surfaces—effect of hydrophilic spacers10.1002/jbm.820221103 ↗
12. Suppression mechanisms for thrombus formation on heparin-immobilized segmented polyurethane-ureas
13. The antiplatelet activity of immobilized prostacyclin10.1002/jbm.820160510 ↗
14. Binding kinetics of thrombin and antithrombin III with immobilized heparin using a spacer10.1097/00002480-199207000-00117 ↗
15. Heparin surface immobilization through hydrophilic spacers: thrombin and antithrombin III binding kinetics10.1163/156856295X00715 ↗
16. Functional reconstitution of thrombomodulin within a substrate-supported membrane-mimetic polymer film10.1021/la025931y ↗
17. Fabrication and characterization of glycocalyx-mimetic surfaces10.1021/la0263864 ↗
18. Cytomimetic biomaterials. 3. Preparation and transport studies of an alginate/amphiphilic copolymer/polymerized phospholipid film10.1163/156856299X00306 ↗
19. A membrane-mimetic barrier for cell encapsulation10.1021/la011254g ↗
20. Cytomimetic biomaterials. 4. In-situ photopolymerization of phospholipids on an alkylated surface10.1021/ma9915780 ↗
21. Cytomimetic biomaterials. 1. In-situ polymerization of phospholipids on an alkylated surface10.1021/ma970481f ↗
22. Synthesis and terminal functionalization of a polymerizable phosphatidylethanolamine10.1021/bc015502w ↗
23. Spectrophotometric determination of avidin and biotin10.1016/0076-6879(71)18342-5 ↗
24. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III10.1016/S0021-9258(18)34385-0 ↗
25. The rate-determining step of the heparin-catalyzed antithrombin/thrombin reaction is independent of thrombin10.1016/S0021-9258(19)83781-X ↗
26. Antithrombin activity of surface-bound heparin studied under flow conditions10.1002/jbm.820291013 ↗
27. The binding of low molecular weight heparin to hemostatic enzymes10.1016/S0021-9258(19)70430-X ↗
28. Quantification of tight binding to surface-immobilized phospholipid vesicles using surface plasmon resonance: binding constant of phospholipase A210.1021/ja993879v ↗
29. Surface plasmon resonance measurement of binding and dissociation of wild-type and mutant streptavidin on mixed biotin-containing alkylthiolate monolayers10.1016/S0925-4005(98)00332-3 ↗
30. Molecular recognition at a self-assembled monolayers: optimization of surface functionalization10.1063/1.465447 ↗
31. Molecular recognition at self-assembled monolayers: the construction of multicomponent multilayers10.1021/la00031a033 ↗
32. Supramolecular engineering at functionalized surfaces10.1016/0379-6779(93)91193-6 ↗
33. Theory of the kinetics of reactions catalyzed by enzymes attached to membranes10.1002/bit.260160107 ↗
34. The kinetics of immobilized enzyme systems10.1016/S0076-6879(80)64011-7 ↗
35. The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex10.1016/0026-2862(90)90031-L ↗
36. Measurement of enzyme kinetics using microscale steady-state kinetic analysis10.1021/la0498859 ↗
37. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma10.1182/blood.V61.1.111.111 ↗
38. Some properties of antithrombin-III and its concentration in human plasma10.1016/0049-3848(80)90190-5 ↗
39. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin10.1016/S0021-9258(19)77932-0 ↗